Incidence of helicobacter pylori infections and therapy for anastomotic ulcers and residual gastritis in patients with residual stomachs

Journal of Infection and Chemotherapy

Volumn 3, Issue 4, 1997, Pages 205-208

  Okabe, Norimasa ^a  

^a Kanagawa Prefecture Nurses and Midwives Training School Hospital   (Japan)

Author keywords

Clarithromycin; H. Pylori; Lansoprazole; Residual stomach

Indexed keywords

EID: 27144456613     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02490036     Document Type: Article

References (11)

1. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: IARC, 1994;61:270.
2. Soll AH. Medical treatment of peptic ulcer disease. JAMA 1996;275:622-629.
3. Lind T, van Zanten SV, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antibiotics: the MACH 1 study. Helicobacter 1996;1:138-144.
4. Hopkins RJ, Girardi LS, Turney EA. Special report and reviews. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-1252.
5. Takimoto T, Kimura K, Taniguchi Y, et al. Dual therapy with lansoprozole and clarithromycin for eradication of Helicobacter pylori. Eur J Gastroenterol 1995;7(suppl 1): S63-S66.
6. Kato M, Asaka M, Kudo M, et al. Effects of lansoprazole plus amoxicillin on curing Helicobacter pylori infections in Japanese peptic ulcer patients. Aliment Pharmacol Ther 1996;10:821-827.
7. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991;35:490-496.
8. Sakita T, Fukutomi H, et al. Diagnosis of stomach ulcer, all cases of stomach and duodenal ulcer. Internal Medicine Series 2. Tokyo: Nankodo, 1972;200-211.
9. Okabe N, Masaoka N, Matsumoto F, et al. Current alteration of Helicobacter pylori in gastro-duodenal disease. J Infect Dis 1992;66:1411-1415.
10. Fujioka T, Kawasaki H, SuWW, et al. In vitro anti-microbial activity against H. pylori and clinical efficacy of various drugs. Japan J Clin Med 1993;51:3255-3259.
11. Logan RPH, Bardhan KD, Celestin LR, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther 1995;9:417-423.